Evidence map›Paper›PMID 35562420›Full record

Trial reportHypertension research : official journal of the Japanese Society of Hypertension2022

The effect of calcium and vitamin D supplements on blood pressure in postmenopausal women: myth or reality?

Farnaz Sharifi, Reza Heydarzadeh, Reza Golchin Vafa, Mohammadhossein Rahmani, Mohammadjavad Mehdizadeh Parizi, Amin Ahmadi, Bardia Zamiri, Mohammad Montaseri, Javad Kojuri

Registry-linked trialAbstract readRandomized Controlled Trial
PubMed Publisher
In one paragraph

Trial report in Hypertension research : official journal of the Japanese Society of Hypertension, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04618952 (The Effect of Calcium-D Supplements on the Blood Pressure of Postmenopausal Women, Myth or Reality ? A Triple-blind Randomized Clinical Trial), which is not on this map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04618952 phase4completednot on this map

The Effect of Calcium-D Supplements on the Blood Pressure of Postmenopausal Women, Myth or Reality ? A Triple-blind Randomized Clinical Trial

TypeinterventionalSponsorShiraz University of Medical SciencesRan2019 to 2020Enrolled98ConditionsHypertensionArmsCalcium D, Placebo
3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Vitamin D and hypertension: Is there any significant relation?Chronic diseases and translational medicine · 2024
    Article
  3. 2023 update and perspectives.Hypertension research : official journal of the Japanese Society of Hypertension · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Farnaz SharifiCardiology Department, Shiraz University of Medical Sciences, Shiraz, Iran.
Reza HeydarzadehProfessor Kojuri Cardiology Clinic, Shiraz, Iran.
Reza Golchin VafaProfessor Kojuri Cardiology Clinic, Shiraz, Iran.
Mohammadhossein RahmaniProfessor Kojuri Cardiology Clinic, Shiraz, Iran.
Mohammadjavad Mehdizadeh PariziProfessor Kojuri Cardiology Clinic, Shiraz, Iran.
Amin AhmadiProfessor Kojuri Cardiology Clinic, Shiraz, Iran.
Bardia ZamiriProfessor Kojuri Cardiology Clinic, Shiraz, Iran.
Mohammad MontaseriProfessor Kojuri Cardiology Clinic, Shiraz, Iran.
Javad KojuriCardiology Department, Shiraz University of Medical Sciences, Shiraz, Iran. Kojurij@yahoo.com.
Shiraz University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hypertension is a highly prevalent disease with serious cardiovascular and renal complications. Many studies have demonstrated a weak correlation between the consumption of calcium (or calcium plus vitamin D) and blood pressure, suggesting that calcium supplements might reduce blood pressure. However, the results to date remain controversial. In this study, we assessed the effect of calcium and vitamin D supplementation on the blood pressure of postmenopausal women with hypertension as a population group in which the use of calcium supplements is prevalent. This triple-blind randomized clinical trial enrolled 98 women of postmenopausal age with hypertension in 2019. The study period was 8 weeks with close follow-up. We used 24-h ambulatory blood pressure monitoring to record the initial and final blood pressure in all participants. The changes in both the mean systolic (p = 0.047) and diastolic blood pressure (p = 0.015) were suggestive of an increase in blood pressure after consuming calcium and vitamin D supplements. Among patients who had been using calcium channel blockers, calcium and vitamin D supplementation caused a notable increase compared to baseline systolic (p = 0.019) and diastolic blood pressures (p = 0.001). The present results differ from those of previous studies. This suggests that calcium supplementation for postmenopausal women with hypertension requires the close observation of blood pressure to prevent any further increase, especially in women who are being treated with calcium channel blockers (clinicaltrial.gov registration: NCT04618952).

Indexed as

HypertensionVitamin DBlood PressureBlood Pressure Monitoring, AmbulatoryCalciumDietary SupplementsDouble-Blind MethodFemaleHumansPostmenopauseCalciumVitamin DAmbulatory blood pressure monitoringCalcium; Vitamin DHypertensionPostmenopausal women

Identifiers

PMID35562420
OpenAlexW4280627784

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.